anim
anim
anim
  • All Categories
  • E-Services
  • NahdiNahdi Global
  • FlashFlash Sales
  • PromoPromo Flyer
  • NahdicareNahdicare Health center
  • MilkMilk Promo Flyer
  • Home
  • Rx Treatments
  • Respiratory Treatments
  • Asthma Relief
  • Genuine  brands

    Genuine brands


  • Temperature Controlled

    Temperature Controlled


  • Secure Payment

    Secure Payment

About Product

Product Description



  • AIRSUPRA is a pressurized inhalation suspension combining 90 mcg of salbutamol (a short-acting beta2-agonist) and 80 mcg of budesonide (an inhaled corticosteroid) per actuation.

  • It is indicated for the as-needed treatment or prevention of bronchoconstriction and the reduction of exacerbation risk in asthma patients aged 18 and older.

  • Clinical studies, such as MANDALA and DENALI, demonstrate that the combination significantly reduces severe asthma exacerbations and improves lung function compared to monotherapies.



How To Use



  • For relief of bronchoconstriction, administer 2 actuations (delivering a total of 180 mcg salbutamol and 160 mcg budesonide) as needed.

  • For prevention of exercise-induced bronchoconstriction, administer 2 actuations 15 to 30 minutes prior to physical activity.

  • Do not exceed a maximum of 6 doses (12 inhalations) within a 24-hour period.

  • No dosage adjustment is required for elderly patients; however, safety and effectiveness have not been established for adolescents aged 12 to 17.



Warnings And Precautions



  • Contraindicated in patients with known hypersensitivity to salbutamol, budesonide, or any of the formulation excipients.

  • Patients should seek immediate medical advice if they experience a paradoxical bronchospasm or if increased bronchodilator use is required, as this indicates worsening asthma control.

  • Use with caution in patients with cardiovascular disorders (e.g., severe heart disease, hypertension), thyrotoxicosis, or hypokalaemia.

  • Usage during pregnancy or breastfeeding should only be considered if the expected benefit to the mother outweighs the potential risks to the fetus or infant.

  • Avoid concomitant use with non-selective beta-blockers and exercise caution with strong CYP3A4 inhibitors (e.g., ketoconazole).



Ingredients



  • Active Ingredients: Salbutamol (90 mcg per actuation) and Budesonide (80 mcg per actuation).

  • Propellant: Norflurane (HFA-134a).

  • Excipients: 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) and Calcium Chloride.

Product Details:

  • Brand: Airsupra
  • Product Form: AIRSUPRA

Asthma Relief
Respiratory Treatments
Rx Treatments
Airsupra

Airsupra 90mcg/80mcg 120 Inhalations

103.10 SAR

  • Brand: Airsupra
  • Product Form: AIRSUPRA

Product Description



  • AIRSUPRA is a pressurized inhalation suspension combining 90 mcg of salbutamol (a short-acting beta2-agonist) and 80 mcg of budesonide (an inhaled corticosteroid) per actuation.

  • It is indicated for the as-needed treatment or prevention of bronchoconstriction and the reduction of exacerbation risk in asthma patients aged 18 and older.

  • Clinical studies, such as MANDALA and DENALI, demonstrate that the combination significantly reduces severe asthma exacerbations and improves lung function compared to monotherapies.



How To Use



  • For relief of bronchoconstriction, administer 2 actuations (delivering a total of 180 mcg salbutamol and 160 mcg budesonide) as needed.

  • For prevention of exercise-induced bronchoconstriction, administer 2 actuations 15 to 30 minutes prior to physical activity.

  • Do not exceed a maximum of 6 doses (12 inhalations) within a 24-hour period.

  • No dosage adjustment is required for elderly patients; however, safety and effectiveness have not been established for adolescents aged 12 to 17.



Warnings And Precautions



  • Contraindicated in patients with known hypersensitivity to salbutamol, budesonide, or any of the formulation excipients.

  • Patients should seek immediate medical advice if they experience a paradoxical bronchospasm or if increased bronchodilator use is required, as this indicates worsening asthma control.

  • Use with caution in patients with cardiovascular disorders (e.g., severe heart disease, hypertension), thyrotoxicosis, or hypokalaemia.

  • Usage during pregnancy or breastfeeding should only be considered if the expected benefit to the mother outweighs the potential risks to the fetus or infant.

  • Avoid concomitant use with non-selective beta-blockers and exercise caution with strong CYP3A4 inhibitors (e.g., ketoconazole).



Ingredients



  • Active Ingredients: Salbutamol (90 mcg per actuation) and Budesonide (80 mcg per actuation).

  • Propellant: Norflurane (HFA-134a).

  • Excipients: 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) and Calcium Chloride.

Product Details:

  • Brand: Airsupra
  • Product Form: AIRSUPRA
  • Genuine  brands

    Genuine brands


  • Temperature Controlled

    Temperature Controlled


  • Secure Payment

    Secure Payment

  • Brand: Airsupra
  • Product Form: AIRSUPRA